Dr. Boris Decourt is currently an Assistant Professor in the Department of Pharmacology and Neuroscience at the Texas Tech University Health Sciences Center, Lubbock, Texas, USA. He is the Director of the Laboratory on Neurodegeneration and Translational Research with a strong emphasis on Alzheimer's disease. He holds a Ph.D. degree in Neuroscience and Pharmacology from the University of Bordeaux. His research interests are focused on biomarker development and in translational drug development approaches using inflammation modulators to study the molecular pathophysiological changes taking place at the early stages of neurological disorders, with the ultimate goal of slowing down or curing the diseases via early intervention before severe neurodegeneration and dementia occur.
Dr. Boris Decourt is currently an Assistant Professor in the Department of Pharmacology and Neuroscience at the Texas Tech University Health Sciences Center, Lubbock, Texas, USA. He is the Director of the Laboratory on Neurodegeneration and Translational Research with a strong emphasis on Alzheimer's disease. He holds a Ph.D. degree in Neuroscience and Pharmacology from the University of Bordeaux. His research interests are focused on biomarker development and in translational drug development approaches using inflammation modulators to study the molecular pathophysiological changes taking place at the early stages of neurological disorders, with the ultimate goal of slowing down or curing the diseases via early intervention before severe neurodegeneration and dementia occur.